首页> 外国专利> injectable formulation for fat tissue accumulus, pharmaceutical composition, uses a long-acting selective beta-adrenergic receptor agonist and a compound, and, of a composition

injectable formulation for fat tissue accumulus, pharmaceutical composition, uses a long-acting selective beta-adrenergic receptor agonist and a compound, and, of a composition

机译:用于脂肪组织蓄积的注射剂,药物组合物,使用长效选择性β-肾上腺素能受体激动剂和化合物,以及一种组合物

摘要

INJECTABLE FORMULATION OF ADIPOSE FABRIC, PHARMACEUTICAL COMPOSITION, USES A SELECTIVE LONG-ACTION AND COMPOSITION BETA-ADRENERGIC RECEIVER AGONIST, AND OF A COMPOSITION. Compositions, formulations, methods and systems for treating regional fat deposits comprise contacting a target fat deposit with a composition comprising long-acting beta-2 adrenergic receptor agonist and a compound for reducing target tissue desensitization to the agonist. long-acting beta-2 adrenoceptor receptor, for example glucocorticosteroids and / or ketotifen. Embodiments of the composition are administered, for example by injection, and / or transdermally.
机译:脂肪纤维,药物组合物的注射剂配方,选择性长效和组合物β-肾上腺素能受体激动剂及组合物。用于治疗局部脂肪沉积物的组合物,制剂,方法和系统包括使目标脂肪沉积物与包含长效β2肾上腺素能受体激动剂和减少目标组织对激动剂的脱敏作用的化合物的组合物接触。长效β-2肾上腺素受体,例如糖皮质激素和/或酮替芬。所述组合物的实施方案例如通过注射和/或透皮给药。

著录项

  • 公开/公告号BRPI0613034A2

    专利类型

  • 公开/公告日2013-01-08

    原文格式PDF

  • 申请/专利权人 LITHERA INC.;

    申请/专利号BR2006PI13034

  • 发明设计人 JOHN DANIEL DOBAK;

    申请日2006-07-13

  • 分类号A61K31/66;A01N57;

  • 国家 BR

  • 入库时间 2022-08-21 16:42:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号